Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating nemolizumab in atopic dermatitis and prurigo nodularis, respectively, at the 2024 European Academy of Dermatology and Venereo…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=997425&sourceType=rss
